DMTK DermTech Inc

Price (delayed)

$27.6

Market cap

$817.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.11

Enterprise value

$587.92M

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform ...

Highlights
The revenue has surged by 100% year-on-year and by 33% since the previous quarter
DermTech's debt has decreased by 8% from the previous quarter
The net income has dropped by 87% year-on-year and by 17% since the previous quarter
DermTech's EPS has decreased by 6% YoY

Key stats

What are the main financial stats of DMTK
Market
Shares outstanding
29.61M
Market cap
$817.25M
Enterprise value
$587.92M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.99
Price to sales (P/S)
87.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.42
Earnings
Revenue
$9.13M
EBIT
-$51.03M
EBITDA
-$50.29M
Free cash flow
-$40.01M
Per share
EPS
-$2.11
Free cash flow per share
-$1.38
Book value per share
$9.24
Revenue per share
$0.31
TBVPS
$9.51
Balance sheet
Total assets
$275.7M
Total liabilities
$8.39M
Debt
$282,000
Equity
$267.31M
Working capital
$264.61M
Liquidity
Debt to equity
0
Current ratio
35.63
Quick ratio
35.39
Net debt/EBITDA
4.56
Margins
EBITDA margin
-551.1%
Gross margin
12.8%
Net margin
-558.9%
Operating margin
-543.3%
Efficiency
Return on assets
-30.6%
Return on equity
-32%
Return on invested capital
-129.9%
Return on capital employed
-19%
Return on sales
-559.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DMTK stock price

How has the DermTech stock price performed over time
Intraday
-3.66%
1 week
-8.94%
1 month
-20.3%
1 year
125.67%
YTD
-14.92%
QTD
-14.05%

Financial performance

How have DermTech's revenue and profit performed over time
Revenue
$9.13M
Gross profit
$1.17M
Operating income
-$49.58M
Net income
-$51M
Gross margin
12.8%
Net margin
-558.9%
The revenue has surged by 100% year-on-year and by 33% since the previous quarter
The net income has dropped by 87% year-on-year and by 17% since the previous quarter
The operating income has plunged by 79% YoY and by 19% from the previous quarter
DermTech's net margin has increased by 12% from the previous quarter and by 7% YoY

Growth

What is DermTech's growth rate over time

Valuation

What is DermTech stock price valuation
P/E
N/A
P/B
2.99
P/S
87.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.42
DermTech's EPS has decreased by 6% YoY
The price to book (P/B) is 85% lower than the 5-year quarterly average of 19.5 and 52% lower than the last 4 quarters average of 6.2
DermTech's equity has increased by 4.1% from the previous quarter
The revenue has surged by 100% year-on-year and by 33% since the previous quarter
The stock's P/S is 25% below its last 4 quarters average of 117.3

Efficiency

How efficient is DermTech business performance
The return on equity has surged by 54% year-on-year and by 21% since the previous quarter
The company's return on assets rose by 50% YoY and by 20% QoQ
DermTech's return on invested capital has increased by 13% QoQ
DermTech's ROS has increased by 12% from the previous quarter and by 6% YoY

Dividends

What is DMTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DMTK.

Financial health

How did DermTech financials performed over time
DermTech's total liabilities has increased by 46% YoY and by 2.4% from the previous quarter
The total assets has increased by 4% since the previous quarter
DermTech's debt is 100% less than its equity
DermTech's debt has decreased by 8% from the previous quarter
DermTech's equity has increased by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.